For example, in breast cancer, high expression of CYP24A1 is associated with tumor progression, and amplification of CYP24A1 locus at 20q is an adverse prognostic factor for recurrence free survival in ER+ breast cancer (Davis et al., 2007; Zhalehjoo et al., 2017). This evidence concerns the gene CYP24A1 and breast cancer.